Akero Therapeutics Inc.

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

In a filing, Akero Therapeutics Inc revealed its Chief Development Officer Yale Catriona unloaded Company’s shares for reported $0.35 million

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

Akero Therapeutics Inc’s filing revealed that its Chief Development Officer Yale Catriona unloaded Company’s shares for reported $0.35 million on

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

In a filing, Akero Therapeutics Inc revealed its Chief Development Officer Yale Catriona unloaded Company’s shares for reported $0.51 million

Stock Earnings

In a filing, Akero Therapeutics Inc revealed its President and CEO Cheng Andrew unloaded Company’s shares for reported $2.0 million

Stock Earnings

Akero Therapeutics Inc’s recent filing unveils that its Chief Operating Officer Young Jonathan unloaded Company’s shares for reported $0.28 million

Analysts Viewpoint

Akero Therapeutics Inc’s recent filing unveils that its Chief Operating Officer Young Jonathan unloaded Company’s shares for reported $0.28 million

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Akero Therapeutics

Tag: Akero Therapeutics Inc.